Your browser doesn't support javascript.
Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz, Tomer; Biragyn, Arya; Frenkel-Morgenstern, Milana; Weissberg, Orly; Gorohovski, Alessandro; Merzon, Eugene; Green, Ilan; Iulita, Florencia; Flores-Aguilar, Lisi; Dierssen, Mara; De Toma, Ilario; Lifshitz, Hefziba; Antonarakis, Stylianos E; Yu, Eugene; Herault, Yann; Potier, Marie-Claude; Botté, Alexandra; Roper, Randall; Sredni, Benjamin; Sarid, Ronit; London, Jacqueline; Mobley, William; Strydom, Andre; Okun, Eitan.
  • Illouz T; The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
  • Biragyn A; The Paul Feder Laboratory On Alzheimer's Disease Research, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
  • Frenkel-Morgenstern M; Laboratory of Molecular Biology and Immunology, NIA, Baltimore, MD, 21224, USA.
  • Weissberg O; Cancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Gorohovski A; Cancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Merzon E; Cancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Green I; Leumit Health Services, Department of Family Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.
  • Iulita F; Leumit Health Services, Department of Family Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.
  • Flores-Aguilar L; Sant Pau Memory Unit, Department of Neurology, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • Dierssen M; Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • De Toma I; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Lifshitz H; Alzheimer-Down Unit, Fundación Catalana Síndrome de Down, Barcelona, Spain.
  • Antonarakis SE; Department of Anatomy and Cell Biology, McGill University, Montreal, Canada.
  • Yu E; Center for Genomic Regulation, The Barcelona Institute for Science and Technology, Barcelona, Spain.
  • Herault Y; University Pompeu Fabra, Barcelona, Spain.
  • Potier MC; Biomedical Research Networking Center for Rare Diseases (CIBERER), Barcelona, Spain.
  • Botté A; Cellular & Systems Neurobiology, Systems Biology Program, The Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), Dr. Aiguader 88, 08003, Barcelona, Spain.
  • Roper R; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Sredni B; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Sarid R; School of Education, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
  • London J; Department of Genetic Medicine and Development, University of Geneva, 1211, Geneva, Switzerland.
  • Mobley W; Medigenome, Swiss Institute of Genomic Medicine, 1207, Geneva, Switzerland.
  • Strydom A; iGE3 Institute of Genetics and Genomics of Geneva, 1211, Geneva, Switzerland.
  • Okun E; The Children's Guild Foundation Down Syndrome Research Program, Genetics and Genomics Program and Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Neuromolecular Med ; 23(4): 574-575, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1536356
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Neuromolecular Med Journal subject: Molecular Biology / Neurology Year: 2021 Document Type: Article Affiliation country: S12017-021-08695-7

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Neuromolecular Med Journal subject: Molecular Biology / Neurology Year: 2021 Document Type: Article Affiliation country: S12017-021-08695-7